STOCKSCREENR

ABT

NYSE

Abbott Laboratories

$90.63-0.70(-0.77%)Mkt Cap: $157.49B

Key Stats

Market Cap

$157.49B

P/E Ratio

25.39

EPS

$3.57

Dividend Yield

2.68%

52-Week Range

$90.29 — $139.06

Volume

14.63M

Avg Volume

12.61M

Beta

0.78

Price Alerts for ABT

Get alerted when ABT hits your target price.

$

Free — enter your email to get started

Valuation

P/E (TTM)

25.39

Forward P/E

15.97

PEG Ratio

-0.47

P/S (TTM)

3.51

P/B (TTM)

3.05

P/FCF

0.00

EV/EBITDA

0.00x

EV/Sales

—

Financial Health

ROE (TTM)

0.12%

ROA (TTM)

0.07%

ROIC

0.00%

Gross Margin

0.56%

Operating Margin

0.18%

Net Margin

0.15%

Debt/Equity

0.29

Current Ratio

1.58

Growth

EPS Growth (YoY)

-0.81%

Revenue Growth (YoY)

+0.04%

EPS Growth (3Y)

+0.22%

EPS Growth (5Y)

+0.24%

Sales Growth (3Y)

+0.01%

Sales Growth (5Y)

+0.06%

EPS Est (This Year)

$5.68

EPS Est (Next Year)

$6.25

Dividends

Dividend Yield

—

Annual Dividend

$0.63

Payout Ratio

0.58%

Frequency

—

Ex-Dividend Date

2026-01-15

Cash/Share

$5.12

Analyst Consensus

2.0

Buy

1 = Strong Buy, 5 = Strong Sell

Price Target Range

$120.00$135.00$152.00
LowMedianHigh

Consensus Target: $134.64(48.6% upside)

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

1.74B

Float

1.73B

Free Float %

99.25%

Technicals

RSI (14)

49.89

SMA 20

$113.12

SMA 50

$116.15

SMA 200

$126.47

ATR (14)

2.14

Volatility (Week)

0.02%

Volatility (Month)

0.01%

Pattern

—

Performance

1 Day

+2.81%

1 Week

-1.30%

1 Month

+3.26%

3 Months

-10.18%

6 Months

-15.27%

1 Year

—

YTD

-9.30%

All-Time High

$141.23

About

Sector

Healthcare

Industry

Medical - Devices

Country

US

Exchange

NYSE

IPO Date

1980-03-17

Employees

114000

CEO

Robert Ford

Index Membership

S&P 500

Website

https://www.abbott.com

Abbott Laboratories (ABT) is a healthcare company in the medical - devices industry listed on the NYSE. With a market capitalization of $157.49B, a P/E ratio of 25.39, and a dividend yield of 2.68%, ABT is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare ABT against other stocks using dozens of fundamental and technical filters.

Similar Stocks

SYK

Stryker Corporation

$315.18

+0.02%

$120.71B

BSX

Boston Scientific Corporation

$57.61

+0.80%

$85.62B

MDT

Medtronic plc

$80.97

+2.02%

$103.96B

EW

Edwards Lifesciences Corporation

$83.50

+2.81%

$48.14B

NVO

Novo Nordisk A/S

$42.22

+4.79%

$187.63B

AZN

AstraZeneca PLC

$187.37

+1.17%

$290.48B

Frequently Asked Questions

What is Abbott Laboratories's P/E ratio?

Abbott Laboratories (ABT) has a trailing twelve-month (TTM) P/E ratio of 25.39. This is near the market average range. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Abbott Laboratories pay a dividend?

No, Abbott Laboratories (ABT) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Abbott Laboratories's market cap?

Abbott Laboratories (ABT) has a market capitalization of $157.49 billion, classifying it as a large-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.

What do analysts think about ABT?

Wall Street analysts have a consensus "Buy" rating on Abbott Laboratories (ABT) with an average score of 2.00 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell). The consensus price target of $134.64 implies 48.6% upside from the current price.

How has ABT performed this year?

Abbott Laboratories (ABT) has returned -9.30% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.